Antidiabetic Properties of Rose Hip

Effects of Rose Hip Intake on Risk Markers of Type 2 Diabetes and Cardiovascular Disease: a Randomized Double-blind Cross-over Investigation in Obese Persons

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01316016

Enrollment

Registered

2011-03-16

Start date

2009-04-30

Completion date

2011-01-31

Last updated

2011-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, glucose intolerance, cholesterol, blood pressure

Brief summary

The purpose of this study is to determine whether daily intake of a drink containing rose hip powder reduces risk markers of type diabetes and cardiovascular disease.

Interventions

DIETARY_SUPPLEMENTRose hip

40 g of rose hip powder daily for 6 weeks.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* BMI \> 30 * willingness to participate in the study * willingness to comply with the daily intake of drinks and the recommended energy intake during the course of the study

Exclusion criteria

* diabetes * previous or ongoing insulin treatment * abnormal thyroid status * abnormal liver status * abnormal kidney status * known gastrointestinal disorder * pregnancy * suspected allergy to ingredients of the drinks

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026